Application | Comment | Organism |
---|---|---|
medicine | Dyrk1B may serve as a target for therapy in human papillomavirus-associated cancers | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
T198A | site-directed mutagenesis, the mutation reduces the enzyme activity compared to the wild-type enzyme | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
nucleus | the majority of Dyrk1B proteins are localized in the nucleus in both vector and E7 expressing cells | Homo sapiens | 5634 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + p27 | Homo sapiens | p27 phosphorylation at Ser10 and Thr198 | ADP + phospho-p27 | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Purification (Comment) | Organism |
---|---|
native enzyme partially from both vector and E7 expressing cells by subcellular fractionation | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
RPE-1 cell | retinal pigmented epithelial cells | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + p27 | p27 phosphorylation at Ser10 and Thr198 | Homo sapiens | ADP + phospho-p27 | - |
? | |
ATP + VSNGSPSLER | a p27-derived peptide, residues 6-15 | Homo sapiens | ADP + VSNGpSPSLER | - |
? |
Synonyms | Comment | Organism |
---|---|---|
dual specificity tyrosine-phosphorylation-regulated kinase 1B | - |
Homo sapiens |
DYRK1B | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | the enzyme is upregulated in cells expressing the high-risk human papillomavirus E7 oncogene, which promotes S-phase entry of host cells from quiescent state in the presence of elevated cell cycle inhibitor p27Kip1 | up |
General Information | Comment | Organism |
---|---|---|
malfunction | knockdown of Dyrk1B by siRNA leads to a modest but statistically significant reduction of BrdU incorporation in RPE1-E7 cells, and reduction of Dyrk1B or mutation T198A significantly reduce S10P in E7 expressing cells | Homo sapiens |
physiological function | enzyme Dyrk1B is a dual-specificity kinase and negative regulator of cell proliferation in quiescent cells. Dyrk1B plays a positive role in S-phase entry of quiescent high-risk human papillomavirus E7 oncogene, HPV E7, expressing cells, and Dyrk1B upregulates HPV E7. Dyrk1B contributes to p27 phosphorylation (at Ser10 and Thr198), which is important for the proliferation of HPV E7 expressing cells. DYRK1B overexpression does not increase S-phase entry in control RPE1 cells | Homo sapiens |